Back to Search
Start Over
Alzheimer's presenilin 1 modulates sorting of APP and its carboxyl-terminal fragments in cerebral neurons in vivo.
- Source :
-
Journal of neurochemistry [J Neurochem] 2007 Aug; Vol. 102 (3), pp. 619-26. - Publication Year :
- 2007
-
Abstract
- Studies in continuously cultured cells have established that familial Alzheimer's disease (FAD) mutant presenilin 1 (PS1) delays exit of the amyloid precursor protein (APP) from the trans-Golgi network (TGN). Here we report the first description of PS1-regulated APP trafficking in cerebral neurons in culture and in vivo. Using neurons from transgenic mice or a cell-free APP transport vesicle biogenesis system derived from the TGN of those neurons, we demonstrated that knocking-in an FAD-associated mutant PS1 transgene was associated with delayed kinetics of APP arrival at the cell surface. Apparently, this delay was at least partially attributable to impaired exit of APP from the TGN, which was documented in the cell-free APP transport vesicle biogenesis assay. To extend the study to APP and carboxyl terminal fragment (CTF) trafficking to cerebral neurons in vivo, we performed subcellular fractionation of brains from APP transgenic mice, some of which carried a second transgene encoding an FAD-associated mutant form of PS1. The presence of the FAD mutant PS1 was associated with a slight shift in the subcellular localization of both holoAPP and APP CTFs toward iodixanol density gradient fractions that were enriched in a marker for the TGN. In a parallel set of experiments, we used an APP : furin chimeric protein strategy to test the effect of artificially forcing TGN concentration of an APP : furin chimera that could be a substrate for beta- and gamma-cleavage. This chimeric substrate generated excess Abeta42 when compared with wildtype APP. These data indicate that the presence of an FAD-associated mutant human PS1 transgene is associated with redistribution of the APP and APP CTFs in brain neurons toward TGN-enriched fractions. The chimera experiment suggests that TGN-enrichment of a beta-/gamma-secretase substrate may play an integral role in the action of mutant PS1 to elevate brain levels of Abeta42.
- Subjects :
- Alzheimer Disease genetics
Alzheimer Disease physiopathology
Amyloid beta-Peptides metabolism
Animals
Animals, Newborn
Cells, Cultured
Cerebral Cortex physiopathology
Flavin-Adenine Dinucleotide metabolism
Humans
Mice
Mice, Transgenic
Mutant Chimeric Proteins genetics
Mutant Chimeric Proteins metabolism
Mutation genetics
Presenilin-1 genetics
Protein Structure, Tertiary physiology
Protein Transport physiology
Transgenes genetics
Up-Regulation physiology
trans-Golgi Network metabolism
Alzheimer Disease metabolism
Amyloid beta-Protein Precursor metabolism
Cerebral Cortex metabolism
Neurons metabolism
Peptide Fragments metabolism
Presenilin-1 metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 0022-3042
- Volume :
- 102
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Journal of neurochemistry
- Publication Type :
- Academic Journal
- Accession number :
- 17630980
- Full Text :
- https://doi.org/10.1111/j.1471-4159.2007.04587.x